New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
基本信息
- 批准号:9753384
- 负责人:
- 金额:$ 37.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcuteAddressAdultAdvocacyAmerican Heart AssociationAreaBlood VesselsBostonCaringChildChildhoodClinicalClinical InvestigatorClinical ResearchClinical TrialsClinical Trials NetworkClinical and Translational Science AwardsCollaborationsCommunity HospitalsComplementDisciplineDiscipline of NursingEducational ActivitiesEmergency MedicineEnrollmentEnvironmentFacultyFundingFutureGeneral HospitalsGoalsHealthHospitalsInfrastructureInpatientsInstitutionInternationalInvestigationIsraelLeadLeadershipLettersMaineMassachusettsMedicalMedical centerMissionMulticenter TrialsNational Institute of Neurological Disorders and StrokeNeurologistNeurologyNew EnglandOperative Surgical ProceduresPatient CarePatient-Focused OutcomesPatientsPediatric HospitalsPediatricsPerformancePhasePhase III Clinical TrialsPhysiciansPopulation HeterogeneityPopulations at RiskPositioning AttributePrincipal InvestigatorProtocols documentationPublic HealthRecording of previous eventsRecordsRecoveryRecurrenceRehabilitation therapyResearchResearch ActivityResearch InfrastructureResearch InstituteResearch PersonnelResearch TrainingResourcesRoleRural HospitalsScienceSeasonsSiteStrokeStroke preventionStrokeNet clinical trialsStudy SectionTalentsTestingTherapeuticTrainingTraining and InfrastructureTranslatingTranslational ResearchUnited States National Institutes of HealthUniversitiesVisionWomanbasedesignearly phase trialexperiencefallsimprovedimproved outcomeinnovationmedical specialtiesmembermetropolitanmultidisciplinarynetwork modelsneuroimagingneurosurgerynext generationnovelnovel therapeuticspatient populationpre-clinicalprogramsrecruitresearch studyskillsstroke clinical trialsstroke neurologystroke rehabilitationstroke riskstroke trialssuccess
项目摘要
We propose to continue the New England Regional Coordinating Center (NERCC), an integrated team of
hospitals and EMS agencies in Boston and Western Massachusetts that will serve as a top-enrolling site and
vibrant contributor to the NINDS Stroke Trials Network. Our group includes many of the major adult academic
stroke centers in the Greater Boston area, and our 30+ hospital New England TeleStroke referral network will
extend our potential recruitment even further. All core hospitals have a proven track record of successful
management and performance of clinical trials. In particular, all hospitals have an established research
infrastructure that performs ongoing clinical research in stroke neurology with strong collaborations across
disciplines. Principal investigator Lee H. Schwamm, MD, and Co-Investigators bring a complementary set of
skills in managing successful translational clinical research programs, membership on Steering Committees,
and positions of national leadership in their fields. Our team includes seasoned clinical investigators in vascular
neurology, emergency medicine, neuroendovascular, neurosurgery, neurointensive care, neuroimaging, stroke
rehabilitation, and preclinical basic and translational stroke investigation in both adults and children. Strengths
of the NERCC team include 1) close personal and professional ties between multiple investigators; 2) large
patient population from diverse hospital settings in a major metropolitan area; 3) talented teams of site
investigators with track records of scientific achievement, innovation, and subject recruitment in multicenter
trials; 4) robust existing NINDS-funded research and clinical trial management infrastructure; 5) existing clinical
research programs, e.g., Neurology Clinical Research Institute, NIH Clinical and Translational Science Award
programs at Boston University and across Harvard; Sites in the SIREN and NeuroNEXT Clinical Coordinating
Center. Overall, the NERCC Team has demonstrated outstanding commitment and performance in the first
StrokeNet cycle, and has the resources, vision, and enthusiasm to continue to develop new translational
science and successfully execute the NINDS StrokeNet Phase 1,2 and 3 trials.
我们建议继续建立新英格兰地区协调中心(NERCC),这是一个由以下人员组成的综合团队:
波士顿和马萨诸塞州西部的医院和 EMS 机构将作为主要招生地点,
NINDS 中风试验网络的充满活力的贡献者。我们的团队包括许多主要的成人学者
大波士顿地区的中风中心以及我们 30 多家新英格兰医院 TeleStroke 转诊网络将
进一步扩大我们的潜在招聘范围。所有核心医院均拥有良好的成功记录
临床试验的管理和执行。特别是,所有医院都有既定的研究
正在进行中风神经病学临床研究的基础设施,并与各个领域进行强有力的合作
学科。首席研究员 Lee H. Schwamm 医学博士和联合研究员带来了一套互补的
管理成功的转化临床研究项目的技能、指导委员会的成员资格、
以及在各自领域的国家领导地位。我们的团队包括经验丰富的血管临床研究人员
神经内科、急诊医学、神经内血管、神经外科、神经重症监护、神经影像学、中风
成人和儿童的康复、临床前基础和转化性中风研究。优势
NERCC 团队的成员包括 1) 多名研究者之间密切的个人和专业联系; 2)大
来自主要大都市地区不同医院环境的患者群体; 3)现场优秀团队
具有多中心科学成就、创新和受试者招募记录的研究人员
试验; 4) 强大的现有 NINDS 资助的研究和临床试验管理基础设施; 5)现有临床
研究项目,例如神经病学临床研究所、NIH 临床和转化科学奖
波士顿大学和哈佛大学的项目; SIREN 和 NeuroNEXT 临床协调站点
中心。总体而言,NERCC团队在第一届比赛中表现出了出色的承诺和表现
StrokeNet 周期,并拥有资源、愿景和热情来继续开发新的转化
科学并成功执行了 NINDS StrokeNet 1、2 和 3 期试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lee H Schwamm其他文献
Breaking up is hard to do: tenecteplase in acute stroke
分手很难做到:替奈普酶治疗急性中风
- DOI:
10.1016/s1474-4422(15)70036-0 - 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Lee H Schwamm - 通讯作者:
Lee H Schwamm
Lee H Schwamm的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lee H Schwamm', 18)}}的其他基金
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
9571496 - 财政年份:2018
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
10306037 - 财政年份:2018
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
9343382 - 财政年份:2016
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8890256 - 财政年份:2013
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8662842 - 财政年份:2013
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8738738 - 财政年份:2013
- 资助金额:
$ 37.78万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Optimizing HEALing in Ohio Communities (OHiO)-Health Equity Supplement
优化俄亥俄州社区 (OHiO) 的治疗 - 健康公平补充
- 批准号:
10890393 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别:
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
- 批准号:
10736443 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别:
Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome
Jansen de Vries 综合征中发现的含有 PPM1D 截短突变的 iPSC 衍生的谷氨酸能神经元的分子分析
- 批准号:
10573782 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别:
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
促进青春期恢复生长的综合治疗 (InTEGRA)
- 批准号:
10680616 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别: